Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes
Autor: | Christoph Wanner, Isabella Zwiener, Robert J. Mentz, Jyothis T. George, Abhinav Sharma, David Fitchett, Nihar R. Desai, Bernard Zinman, Anne Pernille Ofstad, Stefan Hantel, Tariq Ahmad |
---|---|
Rok vydání: | 2021 |
Předmět: |
Oncology
medicine.medical_specialty genetic structures business.industry Type 2 Diabetes Mellitus Type 2 diabetes medicine.disease Outcome (game theory) Phenotype Latent class model Heart failure Internal medicine Empagliflozin medicine Cardiology and Cardiovascular Medicine business Event (probability theory) |
Zdroj: | JACC: Heart Failure. 9:568-577 |
ISSN: | 2213-1779 |
DOI: | 10.1016/j.jchf.2021.03.003 |
Popis: | Objectives Using latent class analysis (LCA) of EMPA-REG OUTCOME (BI 10773 [Empagliflozin] Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients), this study identified d... |
Databáze: | OpenAIRE |
Externí odkaz: |